<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>BioMed Central</PublisherName>
    <PublisherLocation>London</PublisherLocation>
    <PublisherImprintName>BioMed Central</PublisherImprintName>
  </PublisherInfo>
  <Journal OutputMedium="Online">
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12890</JournalID>
      <JournalElectronicISSN>1471-2466</JournalElectronicISSN>
      <JournalTitle>BMC Pulmonary Medicine</JournalTitle>
      <JournalSubTitle>BMC series â€“ open, inclusive and trusted</JournalSubTitle>
      <JournalAbbreviatedTitle>BMC Pulm Med</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="SCH" Type="Primary">Medicine &amp; Public Health</JournalSubject>
        <JournalSubject Code="SCH33134" Priority="1" Type="Secondary">Pneumology/Respiratory System</JournalSubject>
        <JournalSubject Code="SCH33002" Priority="2" Type="Secondary">Internal Medicine</JournalSubject>
        <JournalSubject Code="SCH3100X" Priority="3" Type="Secondary">Intensive / Critical Care Medicine</JournalSubject>
        <SubjectCollection Code="Medicine">SC11</SubjectCollection>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume OutputMedium="Online">
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>16</VolumeIDStart>
        <VolumeIDEnd>16</VolumeIDEnd>
        <VolumeIssueCount>1</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular" OutputMedium="Online">
        <IssueInfo IssueType="Regular" TocLevels="0">
          <IssueIDStart>1</IssueIDStart>
          <IssueIDEnd>1</IssueIDEnd>
          <IssueArticleCount>0</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2016</Year>
              <Month>12</Month>
            </CoverDate>
            <PricelistYear>2016</PricelistYear>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>The Author(s)</CopyrightHolderName>
            <CopyrightYear>2016</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="s12890-016-0252-y" OutputMedium="Online">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>252</ArticleID>
            <ArticleDOI>10.1186/s12890-016-0252-y</ArticleDOI>
            <ArticleCitationID>92</ArticleCitationID>
            <ArticleSequenceNumber>92</ArticleSequenceNumber>
            <ArticleTitle Language="En" OutputMedium="All">Miliary pulmonary nodules due to <Emphasis Type="Italic">Mycobacterium xenopi</Emphasis> in a steroid-induced immunocompromised patient successfully treated with chemotherapy: a case report</ArticleTitle>
            <ArticleCategory>Case report</ArticleCategory>
            <ArticleFirstPage>1</ArticleFirstPage>
            <ArticleLastPage>4</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2016</Year>
                <Month>6</Month>
                <Day>1</Day>
              </RegistrationDate>
              <Received>
                <Year>2016</Year>
                <Month>1</Month>
                <Day>27</Day>
              </Received>
              <Accepted>
                <Year>2016</Year>
                <Month>6</Month>
                <Day>1</Day>
              </Accepted>
              <OnlineDate>
                <Year>2016</Year>
                <Month>6</Month>
                <Day>10</Day>
              </OnlineDate>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>The Author(s).</CopyrightHolderName>
              <CopyrightYear>2016</CopyrightYear>
              <License SubType="CC BY + CC0" Type="OpenAccess" Version="4.0">
                <SimplePara>
                           <Emphasis Type="Bold">Open Access</Emphasis>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ExternalRef>
                    <RefSource>http://creativecommons.org/licenses/by/4.0/</RefSource>
                    <RefTarget Address="http://creativecommons.org/licenses/by/4.0/" TargetType="URL"/>
                  </ExternalRef>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ExternalRef>
                    <RefSource>http://creativecommons.org/publicdomain/zero/1.0/</RefSource>
                    <RefTarget Address="http://creativecommons.org/publicdomain/zero/1.0/" TargetType="URL"/>
                  </ExternalRef>) applies to the data made available in this article, unless otherwise stated.</SimplePara>
              </License>
            </ArticleCopyright>
            <ArticleGrants Type="OpenChoice">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="OpenAccess"/>
              <BodyHTMLGrant Grant="OpenAccess"/>
              <BibliographyGrant Grant="OpenAccess"/>
              <ESMGrant Grant="OpenAccess"/>
            </ArticleGrants>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Yoshio</GivenName>
                  <FamilyName>Okano</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff2" CorrespondingAffiliationID="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Tsutomu</GivenName>
                  <FamilyName>Shinohara</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>+81-88-844-3111</Phone>
                  <Fax>+81-88-843-6385</Fax>
                  <Email>shinoharat@kochi2.hosp.go.jp</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Shino</GivenName>
                  <FamilyName>Imanishi</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Naoki</GivenName>
                  <FamilyName>Takahashi</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Nobuhito</GivenName>
                  <FamilyName>Naito</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Takanari</GivenName>
                  <FamilyName>Taoka</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Naoki</GivenName>
                  <FamilyName>Kadota</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Fumitaka</GivenName>
                  <FamilyName>Ogushi</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Division of Pulmonary Medicine</OrgDivision>
                <OrgName>National Hospital Organization Kochi Hospital</OrgName>
                <OrgAddress>
                  <Street>1-2-25 Asakuranishimachi</Street>
                  <City>Kochi</City>
                  <Postcode>780-8077</Postcode>
                  <Country Code="JP">Japan</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2">
                <OrgDivision>Department of Clinical Investigation</OrgDivision>
                <OrgName>National Hospital Organization Kochi Hospital</OrgName>
                <OrgAddress>
                  <Street>1-2-25 Asakuranishimachi</Street>
                  <City>Kochi</City>
                  <Postcode>780-8077</Postcode>
                  <Country Code="JP">Japan</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En" OutputMedium="All">
              <Heading>Abstract</Heading>
              <AbstractSection ID="ASec1">
                <Heading>Background</Heading>
                <Para ID="Par1">
                           <Emphasis Type="Italic">Mycobacterium xenopi</Emphasis>-infected patients have a high prevalence of pulmonary cavities and nodules. However, the clinical course for patients with miliary nodules due to <Emphasis Type="Italic">M. xenopi</Emphasis> has not yet been reported.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec2">
                <Heading>Case presentation</Heading>
                <Para ID="Par2">We encountered a case of miliary nodules with gradually worsening coughing and sputum production in a 44-year-old male who had renal dysfunction due to glomerulosclerosis with a decade-long history of steroid therapy. Although we started anti-tuberculosis treatment on clinical suspicion of miliary tuberculosis, cultures of sputum and bronchial lavage were both positive for <Emphasis Type="Italic">M. xenopi</Emphasis>. The patient was successfully treated with rifampin, ethambutol and clarithromycin, without fibrosis. It was unclear whether the miliary pattern was induced by hematogenous or endobronchial spread of the <Emphasis Type="Italic">M. xenopi</Emphasis> infection.</Para>
              </AbstractSection>
              <AbstractSection ID="ASec3">
                <Heading>Conclusion</Heading>
                <Para ID="Par3">Even when clinical and radiological disease manifestations are similar to those of miliary tuberculosis, <Emphasis Type="Italic">M. xenopi</Emphasis> infection should be considered in the differential diagnosis of miliary nodules.</Para>
              </AbstractSection>
            </Abstract>
            <KeywordGroup Language="En" OutputMedium="All">
              <Heading>Keywords</Heading>
              <Keyword>
                <Emphasis Type="Italic">Mycobacterium xenopi</Emphasis>
              </Keyword>
              <Keyword>Miliary nodules</Keyword>
              <Keyword>Immunocompromised patient</Keyword>
            </KeywordGroup>
          </ArticleHeader>
          <Body>
            <Section1 ID="Sec1">
              <Heading>Background</Heading>
              <Para ID="Par4">
                        <Emphasis Type="Italic">Mycobacterium xenopi</Emphasis> is one of the common causes of nontuberculous mycobacteria (NTM) pulmonary disease, especially in Canada, France and the United Kingdom [<CitationRef CitationID="CR1">1</CitationRef>â€“<CitationRef CitationID="CR3">3</CitationRef>]. In comparison with <Emphasis Type="Italic">M. avium</Emphasis> complex (MAC), <Emphasis Type="Italic">M. xenopi</Emphasis>-infected patients were found to have a high prevalence of pulmonary cavities and nodules, and rarely present a nodular bronchiectatic form [<CitationRef CitationID="CR4">4</CitationRef>]. A large number of patients with pulmonary cavities due to <Emphasis Type="Italic">M. xenopi</Emphasis> simultaneously had computed tomography (CT) findings of random nodules or consolidation rather than the fibrocavitary form [<CitationRef CitationID="CR4">4</CitationRef>]. The management of individual patients with <Emphasis Type="Italic">M. xenopi</Emphasis> is difficult, since a standard treatment has not been established.</Para>
              <Para ID="Par5">Regarding the random nodules, 4 cases of miliary nodules due to <Emphasis Type="Italic">M. xenopi</Emphasis> with acquired immunodeficiency syndrome were reported by Bankier et al. However, the radiological evaluation of these cases was made by chest X-ray, not by CT. In addition, the clinical course for the patients was not described [<CitationRef CitationID="CR5">5</CitationRef>]. In this report, we present a case of chest CT-proven miliary nodules due to <Emphasis Type="Italic">M. xenopi</Emphasis> without cavities and consolidations in a steroid-induced immunocompromised patient successfully treated with chemotherapy.</Para>
            </Section1>
            <Section1 ID="Sec2">
              <Heading>Case presentation</Heading>
              <Para ID="Par6">A 44-year-old male, who had renal dysfunction due to glomerulosclerosis with a decade-long history of steroid therapy (10â€“20Â mg of prednisone per day), visited our department because of gradually worsening coughing and sputum production. He had no past history of any pulmonary disease, such as chronic obstructive pulmonary disease (COPD), tuberculosis or bronchial asthma. The results of a physical examination were normal. Laboratory data were as follows: white blood cell count, 10630/Î¼l (neutrophils, 91.6Â %); hemoglobin, 12.5Â g/dl; platelet count, 61.2 x 10<Superscript>4</Superscript>/Âµl; C-reactive protein, 6.27Â mg/dl; creatinine, 1.64Â mg/dl. Chest X-ray and CT showed a high number of miliary nodules in both lungs without consolidations or cavities (Fig.Â <InternalRef RefID="Fig1">1a</InternalRef> and <InternalRef RefID="Fig1">b</InternalRef>). Underlying pulmonary diseases, such as emphysema and bronchiectasis, were not observed. Abdominal CT and magnetic resonance imaging of the spine detected no extrapulmonary lesions. Although a sputum acid-fast bacillus smear was positive, polymerase chain reaction (PCR) tests for <Emphasis Type="Italic">M. tuberculosis</Emphasis>, <Emphasis Type="Italic">M. avium</Emphasis> and <Emphasis Type="Italic">M. intracellurare</Emphasis> of the sputum were all negative. On clinical suspicion of miliary tuberculosis, we started quadruple therapy (isoniazid, rifampin (RFP), ethambutol (EB) and pyrazinamide) without dose reduction of prednisone (10Â mg/day). Then, we carried out a bronchoscopic examination, and transbronchial lung biopsy detected small granuloma (Fig.Â <InternalRef RefID="Fig1">1c and d</InternalRef>) and Ziehl-Neelsen staining-positive bacillus bodies (Fig.Â <InternalRef RefID="Fig1">1e</InternalRef>). Acid-fast bacillus smear and PCR tests of bronchial lavage showed the same results as sputum. Later, the culture of sputum and bronchial lavage obtained mycobacterium colonies, and the isolates from both samples were identified as <Emphasis Type="Italic">M. xenopi</Emphasis> by DNA-DNA hybridization (DDH). Since patients infected with <Emphasis Type="Italic">M. heckeshornense</Emphasis> may have been included in the cases that were diagnosed as <Emphasis Type="Italic">M. xenopi</Emphasis> disease by DDH, we reconfirmed that the isolate from bronchial lavage was <Emphasis Type="Italic">M. xenopi</Emphasis> by sequence analyses of the 16S rRNA gene, <Emphasis Type="Italic">rpoB</Emphasis> and <Emphasis Type="Italic">hsp65</Emphasis> [<CitationRef CitationID="CR6">6</CitationRef>]. After the final diagnosis of <Emphasis Type="Italic">M. xenopi</Emphasis> pulmonary infection was established, we changed the quadruple therapy to treatment with RFP (450Â mg/day), EB (750Â mg/day) and clarithromycin (CAM) (800Â mg/day). Chemotherapy was continued for a total period of 15Â months without side effects, and steroid therapy for glomerulosclerosis was also continued without dose modification. Sputum cultures yielded no mycobacteria in the last 12Â months. After the chemotherapy, chest CT showed a prominent reduction in the size and number of miliary nodules without fibrosis (Fig.Â <InternalRef RefID="Fig1">1f</InternalRef>).<Figure Category="Standard" Float="Yes" ID="Fig1">
                  <Caption Language="En">
                    <CaptionNumber>Fig. 1</CaptionNumber>
                    <CaptionContent>
                      <SimplePara>Chest X-ray (<Emphasis Type="Bold">a</Emphasis>), CT (<Emphasis Type="Bold">b</Emphasis> and <Emphasis Type="Bold">f</Emphasis>) and pathological findings of transbronchial lung biopsy (<Emphasis Type="Bold">c</Emphasis> and <Emphasis Type="Bold">d</Emphasis>, hematoxylin and eosin staining; <Emphasis Type="Bold">e</Emphasis>, Ziehl-Neelsen staining). <Emphasis Type="Bold">a</Emphasis> and <Emphasis Type="Bold">b</Emphasis>: A high number of miliary nodules in both lungs without consolidations and cavities at presentation. <Emphasis Type="Bold">c</Emphasis> and <Emphasis Type="Bold">d</Emphasis>: Granulomatous inflammation (<Emphasis Type="Bold">c</Emphasis>, low-power field; <Emphasis Type="Bold">d</Emphasis>, high-power field). <Emphasis Type="Bold">e</Emphasis>: Bacillus bodies seen as a bright red rod. <Emphasis Type="Bold">f</Emphasis>: Marked improvement in miliary nodules after 15Â months of chemotherapy</SimplePara>
                    </CaptionContent>
                  </Caption>
                  <MediaObject ID="MO1">
                    <ImageObject Color="Color" FileRef="MediaObjects/12890_2016_252_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/>
                  </MediaObject>
                </Figure>
                     </Para>
            </Section1>
            <Section1 ID="Sec3">
              <Heading>Discussion</Heading>
              <Para ID="Par7">Clinical and radiological disease manifestations of <Emphasis Type="Italic">M. xenopi</Emphasis> infection vary according to each personâ€™s immunological status, and can be classified into three groups: (1) a cavitary form in patients with pre-existing pulmonary disease; (2) a solitary nodular form in immunocompetent patients and (3) an acute infiltrate form in immunosuppressed patients [<CitationRef CitationID="CR2">2</CitationRef>]. Although multiple small nodules (&lt;5Â mm) coexisting with a predominant form were a common finding in patients with <Emphasis Type="Italic">M. xenopi</Emphasis> pulmonary infection, the mean number is about 10â€“16 per patient [<CitationRef CitationID="CR4">4</CitationRef>, <CitationRef CitationID="CR7">7</CitationRef>]. Therefore, the CT-proven miliary pattern without cavities and consolidations observed in our immunocompromised patient could be a distinct entity.</Para>
              <Para ID="Par8">Previously, Oâ€™Connell et al. reported an autopsy-based series of pulmonary or disseminated nontuberculous mycobacterial disease. In that report, a miliary pattern was noted in 2 of the 5 disseminated patients with mycobacterial lung involvement, but not in the 11 primary pulmonary mycobacterial diseases without extrapulmonary infection [<CitationRef CitationID="CR8">8</CitationRef>]. In addition, miliary pulmonary infection with a macropapular rash on extremities caused by <Emphasis Type="Italic">M. terrae</Emphasis> in an immunocompromised patient was reported [<CitationRef CitationID="CR9">9</CitationRef>]. Miliary pulmonary infection due to nontuberculous mycobacteria in a patient without extrapulmonary infections may be  extremely rare.</Para>
              <Para ID="Par9">Although a miliary pattern is usually induced by the hematogenous spread of infection or tumor cells, this pattern with or without ground-glass opacities sometimes can be seen in so-called hot tub lung (HTL) caused by inhalation of water aerosol containing NTM, especially the MAC [<CitationRef CitationID="CR10">10</CitationRef>â€“<CitationRef CitationID="CR12">12</CitationRef>]. There seems to be quite a controversy over whether HTL is a direct appearance of mycobacterial infection or is a hypersensitivity pneumonitis (HP). Because the sputum cultures continued to be positive for 6Â weeks after initiation of chemotherapy, an infectious process was probably involved in the pathogenesis in our case. While acid-fast bacillus cultures of sputum, tissue and bronchial lavage from patients with HTL are positive at high rates, HTL usually manifests spontaneous or steroid-induced improvement after cessation of hot tub exposure without antimycobacterial treatment [<CitationRef CitationID="CR12">12</CitationRef>]. It was also reported in a mouse model that HTL develops through mycobacterial engagement with Toll-like receptor 9/Myeloid differentiation factor 88 signaling in pulmonary CD11b-positive dendritic cells, regardless of the mycobacterial infectious capacity [<CitationRef CitationID="CR13">13</CitationRef>]. In addition, intravesical administration of bacillus Calmette-Guerin (BCG) against urothelial cancer occasionally induces systemic hypersensitivity reactions, including pneumonitis, without detection of BCG in corresponding organs [<CitationRef CitationID="CR14">14</CitationRef>]. These data indicate that NTMs have pathogenic potential not only as infectious microorganisms, but also as highly immunogenic substances for HP. Although HTL generally appears in immunocompetent patients with no preexisting lung disease [<CitationRef CitationID="CR12">12</CitationRef>], the hypersensitivity phenomenon may have overlapped, to a greater or lesser degree, with an infectious process in the pathogenesis in our case. From the above-mentioned points, the possibility remains that the miliary pattern of our patient resulted from endobronchial spread of the <Emphasis Type="Italic">M. xenopi</Emphasis> infection with hypersensitivity to <Emphasis Type="Italic">M. xenopi</Emphasis> antigens.</Para>
              <Para ID="Par10">Although a standard treatment for <Emphasis Type="Italic">M. xenopi</Emphasis> has not been established, ATS/IDSA recommends an RFP, EB and CAM-containing regimen [<CitationRef CitationID="CR15">15</CitationRef>]. In general, the prognosis for the hematogenous spread of infection in immunocompromised patients is poor, but a prognosis for NTM miliary infection has not been well documented. In this case, treatment with RFP, EB and CAM was effective for miliary pulmonary infection caused by <Emphasis Type="Italic">M. xenopi</Emphasis> even in an immunocompromised patient. Further clinical studies on the pathophysiology related to <Emphasis Type="Italic">M. xenopi</Emphasis> miliary infection are needed in order to improve the management of this rare condition.</Para>
            </Section1>
            <Section1 ID="Sec4">
              <Heading>Conclusion</Heading>
              <Para ID="Par11">
                        <Emphasis Type="Italic">M. xenopi</Emphasis> infection should be considered in the differential diagnosis of miliary pulmonary nodules, even when the clinical and radiological disease manifestations are similar to those of miliary tuberculosis.</Para>
            </Section1>
            <Section1 ID="Sec5">
              <Heading>Abbreviations</Heading>
              <Para ID="Par12">NTM, nontuberculous mycobacteria; <Emphasis Type="Italic">M. xenopi</Emphasis>, <Emphasis Type="Italic">Mycobacterium xenopi</Emphasis>; MAC, <Emphasis Type="Italic">M. avium</Emphasis> complex; CT, computed tomography; COPD, chronic obstructive pulmonary disease; PCR, polymerase chain reaction; RFP, rifampin; EB, ethambutol; DDH, DNA-DNA hybridization; CAM, clarithromycin; HTL, hot tub lung; HP, hypersensitivity pneumonitis; BCG, bacillus Calmette-Guerin</Para>
            </Section1>
          </Body>
          <BodyRef FileRef="BodyRef/PDF/12890_2016_Article_252.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Acknowledgments>
              <Heading>Acknowledgements</Heading>
              <SimplePara>We thank Keishi Naruse (Division of Pathology, National Hospital Organization National Kochi Hospital), Yukihisa Komatsu (Division of Radiology, National Hospital Organization National Kochi Hospital) for their contributions, and Yuko Kazumi (Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association) for molecular genetic studies.</SimplePara>
              <FormalPara ID="FPar1" RenderingStyle="Style1">
                <Heading>Funding</Heading>
                <Para ID="Par13">No funding has been received for this project.</Para>
              </FormalPara>
              <FormalPara ID="FPar2" RenderingStyle="Style1">
                <Heading>Availability of data and materials</Heading>
                <Para ID="Par14">All the data supporting our findings is contained within the manuscript.</Para>
              </FormalPara>
              <FormalPara ID="FPar3" RenderingStyle="Style1">
                <Heading>Authorsâ€™ contributions</Heading>
                <Para ID="Par15">YO drafted the initial manuscript. TS edited and submitted the manuscript. SI, NT, NN, TT, and NK were involved in diagnosing and treating the patient. FO was the attending physician throughout the disease course. All authors read and approved the final manuscript.</Para>
              </FormalPara>
              <FormalPara ID="FPar4" RenderingStyle="Style1">
                <Heading>Competing interests</Heading>
                <Para ID="Par16">The authors declare that they have no competing interests.</Para>
              </FormalPara>
              <FormalPara ID="FPar5" RenderingStyle="Style1">
                <Heading>Consent for publication</Heading>
                <Para ID="Par17">Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</Para>
              </FormalPara>
              <FormalPara ID="FPar6" RenderingStyle="Style1">
                <Heading>Ethics approval and consent to participate</Heading>
                <Para ID="Par18">Ethical approval to report this case was not required.</Para>
              </FormalPara>
              <FormalPara ID="FPar7" RenderingStyle="Style1">
                <Heading>Framework</Heading>
                <Para ID="Par19">We followed the CARE guidelines.</Para>
              </FormalPara>
            </Acknowledgments>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TK</Initials>
                    <FamilyName>Marras</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Chedore</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Ying</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Jamieson</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997â€“2003</ArticleTitle>
                  <JournalTitle>Thorax</JournalTitle>
                  <VolumeID>62</VolumeID>
                  <FirstPage>661</FirstPage>
                  <LastPage>666</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1136/thx.2006.070797</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>17311842</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>2117272</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997â€“2003. Thorax. 2007;62:661â€“6.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>AndrÃ©jak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FX</Initials>
                    <FamilyName>Lescure</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Pukenyte</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Douadi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Yazdanpanah</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Laurans</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2009</Year>
                  <ArticleTitle Language="En">Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in North-east France</ArticleTitle>
                  <JournalTitle>Thorax</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>291</FirstPage>
                  <LastPage>296</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1136/thx.2008.096842</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>19052044</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>AndrÃ©jak C, Lescure FX, Pukenyte E, Douadi Y, Yazdanpanah Y, Laurans G, et al. Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in North-east France. Thorax. 2009;64:291â€“6.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <InstitutionalAuthorName>Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines</InstitutionalAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society</ArticleTitle>
                  <JournalTitle>Thorax</JournalTitle>
                  <VolumeID>55</VolumeID>
                  <FirstPage>210</FirstPage>
                  <LastPage>218</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1136/thorax.55.3.210</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Thorax. 2000;55:210â€“8.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MC</Initials>
                    <FamilyName>Carrillo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Patsios</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Wagnetz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Jamieson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TK</Initials>
                    <FamilyName>Marras</FamilyName>
                  </BibAuthorName>
                  <Year>2014</Year>
                  <ArticleTitle Language="En">Comparison of the spectrum of radiologic and clinical manifestations of pulmonary disease caused by Mycobacterium avium complex and Mycobacterium xenopi</ArticleTitle>
                  <JournalTitle>Can Assoc Radiol J</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>207</FirstPage>
                  <LastPage>213</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.carj.2013.05.006</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>24325924</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Carrillo MC, Patsios D, Wagnetz U, Jamieson F, Marras TK. Comparison of the spectrum of radiologic and clinical manifestations of pulmonary disease caused by Mycobacterium avium complex and Mycobacterium xenopi. Can Assoc Radiol J. 2014;65:207â€“13.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Bankier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Stauffer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Fleischmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Kreuzer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Strasser</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Mossbacher</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Radiographic findings in patients with acquired immunodeficiency syndrome, pulmonary infection, and microbiologic evidence of Mycobacterium xenopi</ArticleTitle>
                  <JournalTitle>J Thorac Imaging</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>282</FirstPage>
                  <LastPage>288</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1M%2FhtlCrsg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00005382-199810000-00008</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>9799136</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bankier AA, Stauffer F, Fleischmann D, Kreuzer S, Strasser G, Mossbacher U, et al. Radiographic findings in patients with acquired immunodeficiency syndrome, pulmonary infection, and microbiologic evidence of Mycobacterium xenopi. J Thorac Imaging. 1998;13:282â€“8.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Morimoto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Kazumi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Maeda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Yoshimori</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Yoshiyama</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Ogata</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2011</Year>
                  <ArticleTitle Language="En">Mycobacterium heckeshornense lung infection that was diagnosed as Mycobacterium xenopi disease by DNA-DNA hybridization (DDH)</ArticleTitle>
                  <JournalTitle>Intern Med</JournalTitle>
                  <VolumeID>50</VolumeID>
                  <FirstPage>1251</FirstPage>
                  <LastPage>1253</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC38XhsVynsLzK</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2169/internalmedicine.50.4628</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>21628944</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Morimoto K, Kazumi Y, Maeda S, Yoshimori K, Yoshiyama T, Ogata H et al. Mycobacterium heckeshornense lung infection that was diagnosed as Mycobacterium xenopi disease by DNA-DNA hybridization (DDH). Intern Med. 2011;50:1251â€“3.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>TK</Initials>
                    <FamilyName>Marras</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>U</Initials>
                    <FamilyName>Wagnetz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FB</Initials>
                    <FamilyName>Jamieson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Patsios</FamilyName>
                  </BibAuthorName>
                  <Year>2013</Year>
                  <ArticleTitle Language="En">Chest computed tomography predicts microbiological burden and symptoms in pulmonary Mycobacterium xenopi</ArticleTitle>
                  <JournalTitle>Respirology</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>92</FirstPage>
                  <LastPage>101</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1440-1843.2012.02277.x</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>23035668</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Marras TK, Wagnetz U, Jamieson FB, Patsios DA. Chest computed tomography predicts microbiological burden and symptoms in pulmonary Mycobacterium xenopi. Respirology. 2013;18:92â€“101.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>O'Connell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KE</Initials>
                    <FamilyName>Birkenkamp</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DE</Initials>
                    <FamilyName>Kleiner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LR</Initials>
                    <FamilyName>Folio</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Holland</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KN</Initials>
                    <FamilyName>Olivier</FamilyName>
                  </BibAuthorName>
                  <Year>2012</Year>
                  <ArticleTitle Language="En">Lung manifestations in an autopsy-based series of pulmonary or disseminated nontuberculous mycobacterial disease</ArticleTitle>
                  <JournalTitle>Chest</JournalTitle>
                  <VolumeID>141</VolumeID>
                  <FirstPage>1203</FirstPage>
                  <LastPage>1209</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1378/chest.11-0425</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>22194586</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>O'Connell ML, Birkenkamp KE, Kleiner DE, Folio LR, Holland SM, Olivier KN. Lung manifestations in an autopsy-based series of pulmonary or disseminated nontuberculous mycobacterial disease. Chest. 2012;141:1203â€“9.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>EJ</Initials>
                    <FamilyName>Peters</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Morice</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Miliary pulmonary infection caused by Mycobacterium terrae in an autologous bone marrow transplant patient</ArticleTitle>
                  <JournalTitle>Chest</JournalTitle>
                  <VolumeID>100</VolumeID>
                  <FirstPage>1449</FirstPage>
                  <LastPage>1450</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK38%2Fjs1Kmsg%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1378/chest.100.5.1449</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>1935310</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Peters EJ, Morice R. Miliary pulmonary infection caused by Mycobacterium terrae in an autologous bone marrow transplant patient. Chest. 1991;100:1449â€“50.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Fahim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MN</Initials>
                    <FamilyName>Khan</FamilyName>
                  </BibAuthorName>
                  <Year>2011</Year>
                  <ArticleTitle Language="En">An unusual cause of miliary radiographic pattern</ArticleTitle>
                  <JournalTitle>BMJ Case Rep</JournalTitle>
                  <BibArticleDOI>10.1136/bcr.10.2011.5060</BibArticleDOI>
                  <Occurrence Type="PID">
                    <Handle>22669771</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>3233948</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fahim A, Khan MN. An unusual cause of miliary radiographic pattern. BMJ Case Rep. 2011. doi:<ExternalRef>
                    <RefSource>10.1136/bcr.10.2011.5060</RefSource>
                    <RefTarget Address="10.1136/bcr.10.2011.5060" TargetType="DOI"/>
                  </ExternalRef>.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Zota</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Angelis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Fraire</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>McNamee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Kielbasa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DH</Initials>
                    <FamilyName>Libraty</FamilyName>
                  </BibAuthorName>
                  <Year>2008</Year>
                  <ArticleTitle Language="En">Lessons from Mycobacterium avium complex-associated pneumonitis: a case report</ArticleTitle>
                  <JournalTitle>J Med Case Rep</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>152</FirstPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1186/1752-1947-2-152</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>18477401</Handle>
                  </Occurrence>
                  <Occurrence Type="PMCID">
                    <Handle>2396177</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zota V, Angelis SM, Fraire AE, McNamee C, Kielbasa S, Libraty DH. Lessons from Mycobacterium avium complex-associated pneumonitis: a case report. J Med Case Rep. 2008;2:152.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Hanak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Kalra</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TR</Initials>
                    <FamilyName>Aksamit</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TE</Initials>
                    <FamilyName>Hartman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HD</Initials>
                    <FamilyName>Tazelaar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Ryu</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Hot tub lung: presenting features and clinical course of 21 patients</ArticleTitle>
                  <JournalTitle>Respir Med</JournalTitle>
                  <VolumeID>100</VolumeID>
                  <FirstPage>610</FirstPage>
                  <LastPage>615</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.rmed.2005.08.005</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>16194601</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hanak V, Kalra S, Aksamit TR, Hartman TE, Tazelaar HD, Ryu JH. Hot tub lung: presenting features and clinical course of 21 patients. Respir Med. 2006;100:610â€“5.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Daito</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Kikuchi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Sakakibara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Gomi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Damayanti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Zaini</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2011</Year>
                  <ArticleTitle Language="En">Mycobacterial hypersensitivity pneumonitis requires TLR9-MyD88 in lung CD11bâ€‰+â€‰CD11câ€‰+â€‰cells</ArticleTitle>
                  <JournalTitle>Eur Respir J</JournalTitle>
                  <VolumeID>38</VolumeID>
                  <FirstPage>688</FirstPage>
                  <LastPage>701</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BC3MXhsFals7fI</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1183/09031936.00177110</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>21273385</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Daito H, Kikuchi T, Sakakibara T, Gomi K, Damayanti T, Zaini J, et al. Mycobacterial hypersensitivity pneumonitis requires TLR9-MyD88 in lung CD11bâ€‰+â€‰CD11câ€‰+â€‰cells. Eur Respir J. 2011;38:688â€“701.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Israel-Biet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Venet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Sandron</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Ziza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Chretien</FamilyName>
                  </BibAuthorName>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">Pulmonary complications of intravesical Bacille Calmette-GuÃ©rin immunotherapy</ArticleTitle>
                  <JournalTitle>Am Rev Respir Dis</JournalTitle>
                  <VolumeID>135</VolumeID>
                  <FirstPage>763</FirstPage>
                  <LastPage>765</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL2s7lsVOnsw%3D%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>3826901</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Israel-Biet D, Venet A, Sandron D, Ziza JM, Chretien J. Pulmonary complications of intravesical Bacille Calmette-GuÃ©rin immunotherapy. Am Rev Respir Dis. 1987;135:763â€“5.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DE</Initials>
                    <FamilyName>Griffith</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Aksamit</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BA</Initials>
                    <FamilyName>Brown-Elliott</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Catanzaro</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Daley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Gordin</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases</ArticleTitle>
                  <JournalTitle>Am J Respir Crit Care Med</JournalTitle>
                  <VolumeID>175</VolumeID>
                  <FirstPage>367</FirstPage>
                  <LastPage>416</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2sXjtlajsL4%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1164/rccm.200604-571ST</Handle>
                  </Occurrence>
                  <Occurrence Type="PID">
                    <Handle>17277290</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367â€“416.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
